Skip to main content

Dogma BioTech

Dogma BioTech

Type

startup

Founded

2023

Funding captured

$100.0k

Deals captured

2

About Dogma BioTech

Dogma Biotech is a biotechnology company developing next-generation protein therapeutics using glycoengineering and synthetic biology to improve how biologic drugs reach target tissues, particularly for neurological and rare diseases.

Dogma BioTech funding captured (2)

Deal typeStageDateAmountInvestors
GrantUnspecifiedJul 10, 2025$100.0kQB3QB3
************************************************undisclosed****************